Introduction:
Lipid nanoparticles (LNPs) are one of the most clinically advanced candidates for delivering nucleic acids to target cell populations, such as hepatocytes. Once LNPs are
endocytosed, they must release their nucleic acid cargo into the cell cytoplasm. For delivering
messenger RNA (mRNA), delivery into the cytosol is sufficient; however, for delivering DNA,
there is an added diffusional barrier needed to facilitate nuclear uptake for transcription and therapeutic effect.
background:
Lipid nanoparticles (LNPs) are one of the most clinically advanced candidates for delivering nucleic acids to target cell populations, such as hepatocytes. Once LNPs are endocytosed, they must release their nucleic acid cargo into the cell cytoplasm. For delivering mRNA, delivery into the cytosol is sufficient however for delivering DNA there is an added diffusional barrier needed to facilitate nuclear uptake for transcription and therapeutic effect.
Method:
Here, we use fluorescence microscopy to investigate the intracellular fate of different
LNP formulations to determine the kinetics of localization to endosomes and lysosomes. LNPs
used in the studies were prepared via self-assembly using a NanoAssemblr for microfluidic mixing. As the content of polyethylene glycol (PEG) within the LNP formulation influences cellular
uptake by hepatocyte cells, the content and hydrocarbon chain length within the formulation were
assessed for their impact on intracellular trafficking. Standard LNPs were then formed using three
commercially available ionizable lipids, Dlin-MC3-DMA (MC3), Dlin-KC2-DMA (KC2), and
SS-OP. Plasmid DNA (pDNA) and mRNA were used, more specifically with a mixture of Cyanine 3 (Cy3)-labeled and green fluorescence protein (GFP) producing plasmid DNA (pDNA) as
well as Cy5-labeled GFP producing mRNA. After formulation, LNPs were characterized for the
encapsulation efficiency of the nucleic acid, hydrodynamic diameter, polydispersity, and zeta potential. All standard LNPs were ~100 nm in diameter and had neutral surface charge. All LNPs
resulted in encapsulation efficiency greater than 70%. Confocal fluorescence microscopy was used
for the intracellular trafficking studies, where LNPs were incubated with HuH-7 hepatocyte cells
at times ranging from 0-48 h. The cells were antibody-stained for subcellular components, including nuclei, endosomes, and lysosomes.
objective:
The objective of this study was to identify the kinetics of intracellular trafficking and nucleic acid release from lipid nanoparticles containing different lipid compositions in hepatocyte cells.
Result:
Analysis was performed to quantify localization of pDNA to the endosomes and lysosomes. LNPs with 1.5 mol% PEG and a hydrocarbon chain C14 resulted in optimal endosomal
escape and GFP production. Results from this study demonstrate that a higher percentage of C14
PEG leads to smaller LNPs with limited available phospholipid binding area for ApoE, resulting in
decreased cellular uptake. We observed differences in the localization kinetics depending on the
LNP formulation type for SS-OP, KC2, and MC3 ionizable lipids. The results also demonstrate the
technique across different nucleic acid types, where mRNA resulted in more rapid and uniform
GFP production compared to pDNA delivery. CONCLUSION: Here, we demonstrated the ability
to track uptake and the sub-cellular fate of LNPs containing pDNA and mRNA, enabling improved screening prior to in vivo studies which would aid in formulation optimization.
method:
Here, we use fluorescence microscopy to investigate intracellular fate of different LNP formulations to determine the kinetics of localization to endosomes and lysosomes. LNPs used in the studies were prepared via self-assembly using a NanoAssemblr for microfluidic mixing. As the content of polyethylene glycol (PEG) within the LNP formulation influences cellular uptake by hepatocyte cells, the content and hydrocarbon chain length within the formulation were assessed for their impact on intracellular trafficking. Standard LNPs were then formed using three commercially available ionizable lipids, Dlin-MC3-DMA (MC3), Dlin-KC2-DMA (KC2), and SS-OP. Plasmid DNA (pDNA) and messenger RNA (mRNA) were used, more specifically with a mixture of Cyanine 3 (Cy3)-labeled and green fluorescence protein (GFP) producing plasmid DNA (pDNA) as well as Cy5-labeled GFP producing mRNA. After formulation, LNPs were characterized for the encapsulation efficiency of the nucleic acid, hydrodynamic diameter, polydispersity, and zeta potential.
result:
All standard LNPs were ~100 nm in diameter and neutral surface charge. All LNPs resulted in encapsulation efficiency greater than 70%. Confocal fluorescence microscopy was used for the intracellular trafficking studies, where LNPs were incubated with HuH-7 cells at times ranging from 0-48 h. The cells were antibody-stained for subcellular components, including nuclei, endosomes, and lysosomes. Analysis was performed to quantify localization of pDNA to the endosomes and lysosomes. LNPs with 1.5 mol% PEG and a hydrocarbon chain C14 resulted in endosomal escape and GFP production. We observed differences in the localization kinetics depending on LNP formulation type.
conclusion:
Here we demonstrated the ability to track uptake and sub-cellular fate of LNPs containing pDNA and mRNA, enabling improved screening prior to in vivo studies which would aid in formulation optimization.
other:
N/A
